MOTS-C 40 mg bulk research vial — wholesale

For research use only · Not for human consumption · Not for veterinary use. This product is supplied for in-vitro research, analytical method development, and laboratory reference standard use only. Not approved for human or veterinary administration. Buyer is responsible for end-use classification in the destination jurisdiction.

Overview

MOTS-C is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded by the mitochondrial 12S rRNA gene, identified in the academic literature as a peptide that translocates from the mitochondrion to the cytoplasm and to the extracellular space under defined research conditions. MOTS-C 40 mg is the bulk-pack 40 mg research vial format, supplied lyophilized, intended for in-vitro cell-based assays running at higher per-assay mass, mitochondrial-derived peptide pathway research, and reference-standard stock programmes. SPK Pharma India supplies MOTS-C 40 mg as a documented, lot-traceable research compound for distributors, contract manufacturers, and academic laboratories. The disambiguation between the 20 mg and the 40 mg bulk-pack formats is important for research buyers — the two formats are the same peptide, but the 40 mg format is positioned for higher-mass research programmes.

Specifications

Research context

MOTS-C is studied in cell-based research on mitochondrial-derived peptide signalling, on the regulation of cellular energy metabolism, and on the interaction of the peptide with the folate cycle and the AMPK pathway in defined cell-based systems. The Met residues in the sequence are sensitive to oxidation, and the Trp residue is mildly light-sensitive — both are accounted for in the recommended storage and handling conditions.

The 40 mg bulk-pack format is positioned for laboratories running multi-plate cell-based assays, parallel mitochondrial-derived peptide pathway studies, and reference-standard stock programmes where the same lot is referenced across multiple analytical runs. The companion 20 mg research vial format is documented on the MOTS-C 20 mg page. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The compound is supplied strictly for in-vitro research, analytical method development, and reference-standard work.

For researchers new to the compound, the standard analytical reference points are CAS 1627580-64-6, the 16-amino-acid sequence MRWQEMGQIREADLAR, the calculated molecular weight of 2,174.6 g/mol, the lyophilized powder form, and the documented purity threshold (≥99% HPLC).

Packaging and supply

• 40 mg research vial — the bulk-pack 40 mg research format, suitable for multi-plate cell-based assays, dose-response studies, and recurring reference-standard programmes. Standard MOQ: 2 vials.
• Bulk pack — on application, for annual supply contracts and recurring orders.

Distributor pricing is available on application. Annual supply contracts with scheduled recurring dispatch are available for repeat buyers. Lead time for in-stock SKUs is typically 5 business days from purchase order confirmation; lead time for scheduled production is typically 4 to 6 weeks.

Quality and documentation

Every lot of MOTS-C 40 mg ships with a lot-matched Certificate of Analysis documenting identity (mass spectrometry and amino acid analysis), purity (HPLC), appearance, lot number, and synthesis batch reference. A representative sample of every lot is independently verified by a third-party analytical laboratory before release. MSDS is supplied with every shipment. The COA template, the lot-traceability workflow, and the third-party verification scope are documented on the Quality page.

Storage and handling

• Store at -20°C in the original sealed container.
• Protect from light and moisture. The Met residues are mildly oxidation-sensitive; the Trp residue is mildly light-sensitive.
• Allow the sealed container to reach room temperature before opening, to avoid condensation.
• Reconstitute in sterile, low-endotoxin research-grade water or in a mild buffer at the working concentration required by the assay.
• Do not refreeze once reconstituted; aliquot and store at working concentration.
• For longer peptides, avoid vigorous vortexing; allow gentle dissolution to minimise aggregation.

Shipping

MOTS-C 40 mg is shipped lyophilized in sealed vials within temperature-validated packaging. International lanes are routed through dedicated life-science logistics partners with cold-chain handling. Standard dispatch is within 5 business days of purchase order confirmation. SPK Pharma India ships to the United States, the European Union, the United Kingdom, Canada, MENA, APAC, and LATAM. Full export documentation, including commercial invoice, packing list, certificate of origin, COA, and MSDS, is included with every shipment. Destination-specific documentation is supported on request.

Compliance

This product is supplied for research use only. It is not a drug, not a finished dosage form, and not approved for human or veterinary administration. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The buyer is responsible for end-use classification in the destination jurisdiction and for ensuring that downstream handling is consistent with research-use-only protocols.

Lead form CTA

To request a wholesale quote for MOTS-C 40 mg, contact the trade desk with the subject line "MOTS-C 40 mg wholesale quote" and your company details, expected volume, and destination country. Distributor pricing is available on application. The desk responds within one business day.

Related compounds

• MOTS-C 20 mg — standard 20 mg research vial
• SS-31 10 mg — mitochondria-targeted tetrapeptide research peptide
• SS-31 50 mg — bulk-pack mitochondria-targeted tetrapeptide research peptide
• NAD+ — research-grade bulk reference standard
• FOXO4-DRI — 46-amino-acid D-retro-inverso research peptide